-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Olanzapine in Bipolar Disorder (Manic Depression)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Olanzapine in Bipolar Disorder (Manic Depression) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Olanzapine in Bipolar Disorder (Manic Depression) Drug Details: Olanzapine...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Olanzapine in Schizophrenia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Olanzapine in Schizophrenia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Olanzapine in Schizophrenia Drug Details: Olanzapine (NRL-4) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Naronapride in Diabetic Gastroparesis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Naronapride in Diabetic Gastroparesis Drug Details: Naronapride is under development for the treatment of multiple...
-
Product Insights
NewHemangiomas – Drugs In Development, 2024
Empower your strategies with our Hemangiomas – Drugs In Development, 2024 report and make more profitable business decisions. Hemangiomas are the most common benign tumors in infants also known as strawberry marks. It is a non-cancerous vascular tumors caused by endothelial cell proliferation. Strawberry like birth marks appears on the skin within one to three weeks after the birth in around 4-5% of newborns. Most of the hemangiomas subsides without treatment and mostly occurs in premature infants. Superficial hemangioma, deep hemangioma,...
-
Product Insights
NewCavernous Hemangioma (Cerebral Cavernous Malformation/Cerebral Cavernous Hemangioma) – Drugs In Development, 2024
Empower your strategies with our Cavernous Hemangioma (Cerebral Cavernous Malformation/Cerebral Cavernous Hemangioma) – Drugs In Development, 2024 report and make more profitable business decisions. Cavernous hemangioma is also known as cerebral cavernous malformation (CCM), cavernoma, or cavernous angioma. It is an abnormal tangle of tightly packed, thin-walled capillaries that are prone to bleeding. Symptoms include seizures, blurred vision, double vision, loss of vision, weakness in arms or legs, facial drooping, unsteady walk, and headaches. Diagnostic tests include susceptibility weighted imaging (SWI)...
-
Product Insights
NewSeizures – Drugs In Development, 2024
Empower your strategies with our Seizures – Drugs In Development, 2024 report and make more profitable business decisions. A seizure is a medical condition where the patient has a temporary, unstoppable surge of electrical brain activity. Affected brain cells uncontrollably fire signals to others around them, overloading the affected areas of the brain. That overload can cause a wide range of symptoms or effects, including abnormal sensations, passing out, and uncontrolled muscle movements. Up to 11% of people in the US...
-
Product Insights
NewBipolar Disorder (Manic Depression) – Drugs In Development, 2024
Empower your strategies with our Bipolar Disorder (Manic Depression) – Drugs In Development, 2024 report and make more profitable business decisions. Bipolar disorder, previously known as manic depression, is a mental health condition characterized by extreme mood swings that include emotional highs (mania or hypomania) and lows (depression). These mood shifts can significantly impact a person's ability to function in daily life. The exact cause of bipolar disorder is not fully understood, but it is believed to involve a combination of...
-
Product Insights
NewSchizophrenia – Drugs In Development, 2024
Empower your strategies with our Schizophrenia – Drugs In Development, 2024 report and make more profitable business decisions. Schizophrenia is a chronic, severe, and disabling brain disorder that generally appears in late adolescence or early adulthood. Symptoms include delusions, hallucinations, disorganized speech, and disorganized behavior. Risk factors include family history, age, drugs (psychoactive), and weakened immune system. Treatment includes antipsychotic medications. The Schizophrenia drugs in development market research report provide comprehensive information on the therapeutics under development for Schizophrenia, complete with...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NRL-1049 in Cavernous Hemangioma (Cerebral Cavernous Malformation/Cerebral Cavernous Hemangioma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NRL-1049 in Cavernous Hemangioma (Cerebral Cavernous Malformation/Cerebral Cavernous Hemangioma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.NRL-1049 in Cavernous Hemangioma (Cerebral Cavernous Malformation/Cerebral Cavernous...
-
Product Insights
Transmucosal Drug Delivery Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Transmucosal Drug Delivery Pipeline Market Report Overview A Transmucosal drug delivery device is intended for the localized delivery of medications through a mucous membrane. The transmucosal drug delivery pipeline market research report provides comprehensive information about the transmucosal drug delivery pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Key Segment ·      Nasal ·      Vaginal ·      Buccal Delivery ·      Rectal Key Territories ·      The US...